Ying-Li Wu (Yingli Wu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Plasmodium Falciparum

Multiple Myeloma

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Top Venues

Journal of translational medicine

Cell death & disease

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Ying-Li Wu, Wenli Gu
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma. Journal of translational medicine 22 (1) (2024)
Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Ying-Li Wu, Wenli Gu
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma. Journal of translational medicine 22 (1) (2024)
Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Ying-Li Wu, Wenli Gu
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma. Journal of translational medicine 22 (1) (2024)
Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Ying-Li Wu, Wenli Gu
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma. Journal of translational medicine 22 (1) (2024)
Xingming Zhang, Lou Geng, Yi Tang, Yingying Wang, Youping Zhang, Chujiao Zhu, Hu Lei, Hanzhang Xu, Qi Zhu, Ying-Li Wu, Wenli Gu
Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma. Journal of translational medicine 22 (1) (2024)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Lin Qian, Na Li, Xiao-Chen Lu, Mi-Die Xu, Ying Liu, Kaiyue Li, Yi Zhang, Kewen Hu, Yu-Ting Qi, Jun Yao, Ying-Li Wu, Wen-Yu Wen, Shengling Huang, Zheng-Jun Chen, Miao Yin, Qun-Ying Lei
Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nature metabolism (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene (2023)
Hu Lei, Hanzhang Xu, Li Yang, Yingying Wang, Youping Zhang, Ying-Li Wu
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia. Oncogene 43 (7) (2023)
Qi-Xiang Ma, Wen-Ying Zhu, Xiao-Chen Lu, Duo Jiang, Feng Xu, Jin-Tao Li, Lei Zhang, Ying-Li Wu, Zheng-Jun Chen, Miao Yin, Hai-Yan Huang, Qun-Ying Lei
BCAA-BCKA axis regulates WAT browning through acetylation of PRDM16. Nature metabolism 4 (1) (2022)
Huijing Yin, Bo Jing, Dongliang Xu, Wenzheng Guo, Beibei Sun, Jie Zhang, Yueling Liao, Hongyong Song, Tong Wang, Shuli Liu, Yueling Liao, Min Hu, Kaimi Li, Siwei Zhang, Hongjia Zhang, Jianhua Xu, Xue Li, Jing Du, Yadi Wu, Ying-Li Wu, Qi Wang, Feng Yao, Yueh Eugene Chin, Binhua P Zhou, Jiong Deng
Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma. Cancer research 82 (6) (2022)
Xinyi Zeng, Wenbin Xu, Jianjing Tong, Jia Liu, Zilu Zhang, Mei Liu, Chao Wu, Qing Yu, Chenjing Ye, Chengyu Wu, Ying-Li Wu, Hua Yan
SPAG5 as a novel biomarker and potential therapeutic target via regulating AKT pathway in multiple myeloma. Leukemia & lymphoma 63 (11) (2022)
Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Ying-Li Wu, Hua Yan
JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKK. Cancer biology & medicine (2021)
Yang Cao, Huizhuang Shan, Meng Liu, Jia Liu, Zilu Zhang, Xiaoguang Xu, Yue Liu, Hanzhang Xu, Hu Lei, Miao Yu, Xingming Zhang, Wanting Liu, Zhilei Bu, Zhixiao Fang, Yanjie Ji, Hua Yan, Weiying Gu, Ying-Li Wu
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib. Cell death & disease 12 (4) (2021)
Jun Yang, Juan Wang, Yuan Liu, Yu Zhang, Wenjing Huang, Yu Zou, Yanyan Qiu, Weiyang Cai, Jing Gao, Hu Zhou, Ying-Li Wu, Weijun Liu, Qingqing Ding, Yanjie Zhang, Pei-Hao Yin, Wen-Fu Tan
PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell death & disease 12 (7) (2021)
Hu Lei, Han-Zhang Xu, Hui-Zhuang Shan, Meng Liu, Ying Lu, Zhi-Xiao Fang, Jin Jin, Bo Jing, Xin-Hua Xiao, Shen-Meng Gao, Feng-Hou Gao, Li Xia, Li Yang, Li-Gen Liu, Wei-Wei Wang, Chuan-Xu Liu, Yin Tong, Yun-Zhao Wu, Jun-Ke Zheng, Guo-Qiang Chen, Li Zhou, Ying-Li Wu
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia. Nature communications 12 (1) (2021)
Huizhuang Shan, Yang Cao, Xinhua Xiao, Meng Liu, Yunzhao Wu, Qi Zhu, Hanzhang Xu, Hu Lei, Zhu-Jun Yao, Ying-Li Wu
YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma. Signal transduction and targeted therapy 5 (1) (2020)
Lei-Miao Yin, Yu-Dong Xu, Ling-Ling Peng, Ting-Ting Duan, Jia-Yuan Liu, Zhijian Xu, Wen-Qian Wang, Nan Guan, Xiao-Jie Han, Hai-Yan Li, Yu Pang, Yu Wang, Zhaoqiang Chen, Jianming Zhu, Linhong Deng, Ying-Li Wu, Guang-Bo Ge, Shuang Huang, Luis Ulloa, Yong-Qing Yang
Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance. Science translational medicine 10 (427) (2019)
Bo Jing, Jin Jin, Rufang Xiang, Meng Liu, Li Yang, Yin Tong, Xinhua Xiao, Hu Lei, Wei Liu, Hanzhang Xu, Jiong Deng, Li Zhou, Ying-Li Wu
Vorinostat and quinacrine have synergistic effects in T-cell acute lymphoblastic leukemia through reactive oxygen species increase and mitophagy inhibition. Cell death & disease 9 (6) (2018)
Yingying Wang, Linlin Wu, Haiyan Cai, Hu Lei, Chun-Min Ma, Li Yang, Hanzhang Xu, Qi Zhu, Zhujun Yao, Ying-Li Wu
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity. Cell death & disease 9 (11) (2018)
Jia Tong, Qing Yu, Wenbin Xu, Wenjun Yu, Chao Wu, Ying-Li Wu, Hua Yan
Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway. Cancer biology & therapy 20 (3) (2018)
Huizhuang Shan, Xiangyun Li, Xinhua Xiao, Yuting Dai, Jinyan Huang, Junjun Song, Meng Liu, Li Yang, Hu Lei, Yin Tong, Li Zhou, Hanzhang Xu, Ying-Li Wu
USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. Signal transduction and targeted therapy 3 (2018)
Han-Zhang Xu, Zhuo-Qun Wang, Hui-Zhuang Shan, Li Zhou, Li Yang, Hu Lei, Bin Liu, Ying-Li Wu
Overexpression of Fbxo6 inactivates spindle checkpoint by interacting with Mad2 and BubR1. Cell cycle (Georgetown, Tex.) 17 (24) (2018)
Yingying Wang, Linlin Wu, Haiyan Cai, Hu Lei, Chun-Min Ma, Li Yang, Hanzhang Xu, Qi Zhu, Zhujun Yao, Ying-Li Wu
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells. Cell death discovery 4 (2018)